FDA planned to fast-track applications for authorization, but agency reviewers raise alarm over addiction riskPopular nicotine pouch products have yet to be cleared for sale in the United States despite a fast-track Food and Drug Administration scheme, as agency scientists hesitate to authorize them due to potential risks to new users, including children, three sources told Reuters.New tobacco products like…
Source: World news | The Guardian